ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ

<p align="justify">Оценена взаимосвязь уровня растворимого Fas-лиганда (sFas-L) в сыворотке крови с тяжестью и характером течения хронической сердечной недостаточности (ХСН) у больных ишемической болезнью сердца. Обследовано 94 пациента с ХСН. В группу контроля вошли 32 человека, не...

Full description

Bibliographic Details
Main Authors:	Ye. N. Berezikova, M. G. Pustovetova, S. N. Shilov, A. V. Yefremov, I. D. Safronov, Ye. N. Samsonova, A. T. Teplyakov, Yu. Yu. Torim, R. Ye. Tuleutaeva
Format:	Article
Language:	Russian
Published:	Meshalkin National Medical Research Center 2015-10-01
Series:	Патология кровообращения и кардиохирургия
Subjects:	ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ АПОПТОЗ FAS-ЛИГАНД
Online Access:	https://journalmeshalkin.ru/index.php/heartjournal/article/view/161

Similar Items

ЦИТОКИНОВЫЙ ПРОФИЛЬ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

ВЛИЯНИЕ ПОЛИМОРФИЗМА ГЕНА КАСПАЗЫ 8 НА РИСК РАЗВИТИЯ И ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Терапия хронической сердечной недостаточности с позиций доказательной медицины
Published: (2018-06-01)

ПРОБЛЕМА ОТСУТСТВИЯ ОТВЕТА НА КАРДИОРЕСИНХРОНИЗАЦИОННУЮ ТЕРАПИЮ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: S. I. Stupakov
Published: (2015-10-01)

Оптимизация фармакотерапии хронической сердечной недостаточности с помощью отечественного β-адреноблокатора проксадола
Published: (2018-06-01)

Фармакоэкономический анализ применения левосимендана у больных с тяжёлой декомпенсированной хронической сердечной недостаточностью
Published: (2018-06-01)

Исследования с бисопрололом при хронической сердечной недостаточности: CIBIS, CIBIS II и CIBIS III
Published: (2018-06-01)

Место ингибиторов ангиотензин-конвертирующего фермента в терапии хронической сердечной недостаточности
Published: (2018-06-01)

Взаимосвязь механических паттернов блокады левой ножки пучка Гиса и суперответа при сердечной ресинхронизирующей терапии у пациентов с хронической сердечной недостаточностью
Published: (2020-02-01)

Влияние иАПФ на качество жизни и клинические показатели больных хронической сердечной недостаточностью
Published: (2018-06-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

Клинико-экономический анализ севеламера при хронической почечной недостаточности
Published: (2018-06-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

Endokrinnye mekhanizmy modulyatsii serdechnoydeyatel'nosti u patsientov s khronicheskoyserdechnoy nedostatochnost'yu: rol' gormona rosta
Published: (2010-12-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

«Grey zone» of heart failure
by: P Yu Galin, et al.
Published: (2018-08-01)

Russian National Research Medical University named after N.I. Pirogov, Moscow
by: V. N. Larina, et al.
Published: (2015-09-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Tissue Doppler study in the diagnosis of functional disorders of the myocardium in patients with chronic heart failure
by: A S Skosyrev, et al.
Published: (2010-06-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Positive effect of if-channel’s blocker ivabradine therapy in a patient with ischemic chronic heart failure with preserved left ventricle ejection fraction and hereditary thrombophilia (clinical case)
by: Iurii N. Belenkov, et al.
Published: (2019-09-01)

HYPERURICEMIA AS A PREDICTOR OF CHRONIC HEART FAILURE
by: M. V. Ledyakhova, et al.
Published: (2015-09-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

EPIDEMIOLOGICAL ASPECTS OF IDIOPATHIC DILATED CARDIOMYOPATHY
by: A. S. Sisakyan, et al.
Published: (2003-08-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE
by: O. A. Shtegman
Published: (2015-09-01)

EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. M. Zaslavskaya, et al.
Published: (2015-12-01)

RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE
by: T. G. Kulikova, et al.
Published: (2015-09-01)

CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN: ROLE OF CHRONIC PULMONARY OBSTRUCTIVE DISEASE
by: N. T. Vatutin, et al.
Published: (2016-08-01)

The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01)

Clinical efficacy of AT1-receptors of angiotensin II valsartan in the pharmacotherapy of patients with arterial hypertension and chronic heart failure
by: A K Starodubtsev, et al.
Published: (2010-12-01)

Prediktory vyzhivaemosti bol'nykh khronicheskoy serdechnoy nedostatochnost'yu, stradayushchikh sakharnym diabetom 2 tipa
by: Leonid Grigor'evich Strongin, et al.
Published: (2004-12-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

Cannot write session to /tmp/vufind_sessions/sess_l3q6ivhol1gtt219d62aekfclt